Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-24.88	90.84	120.92
Graham Fair Price	189.53	4.77	1.65
PEG	91.89	-0.04	-0.46
Price/Book	258.48	0.60	0.17
Price/Cash Flow	169.93	15.88	-5.88
Prices/Earnings	-95.20	5.90	122.88
Price/Sales	223.57	1.42	0.44
Price/FCF	169.93	15.88	-5.88
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	77.42	0.08	0.05
Operating Margin	1611.52	0.09	< 0.005
ROA	7837.93	< 0.005	< 0.005
ROE	< 0.005	0.03	7363.07
ROIC	< 0.005	0.01	2187.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	< 0.005	336.16
Dividends QOQ	-0.02	-0.58	-2638.01
EBIT QOQ	-0.94	19.03	1914.79
EPS QOQ	-2.69	1.59	-40.74
FCF QOQ	-1.37	2.40	75.71
Revenue QOQ	-0.15	0.17	10.31
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	16.07	10.19	-36.63
Days Sales Outstanding (DSO)	57.54	52.69	-8.44
Inventory Turnover	5.60	8.84	57.81
Debt/Capitalization	0.63	0.61	-3.35
Quick Ratio	0.34	0.36	3.94
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.89	6.33	-66.48
Cash	1.32	0.45	-66.14
Capex	-1.00	-0.14	86.18
Free Cash Flow	-0.53	0.24	-55.49
Revenue	7.16	2.66	-62.87
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.45	0.43	-5.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	109.58	64.66	-40.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating